3-Methylpiperidine → 3-Chloro-5-(3-methylpiperidinosulfonyl)benzoic acid

HRID 1730605노트

반응식

HRID 1730605 반응식
[CH3:1][CH:2]1[CH2:7][CH2:6][CH2:5][NH:4][CH2:3]1.[Cl:8][C:9]1[CH:10]=[C:11]([CH:15]=[C:16]([S:18](Cl)(=[O:20])=[O:19])[CH:17]=1)[C:12]([OH:14])=[O:13]>C(Cl)Cl>[Cl:8][C:9]1[CH:10]=[C:11]([CH:15]=[C:16]([S:18]([N:4]2[CH2:5][CH2:6][CH2:7][CH:2]([CH3:1])[CH2:3]2)(=[O:20])=[O:19])[CH:17]=1)[C:12]([OH:14])=[O:13]

참가 물질

4

실험 절차

The procedure of Example 43 is repeated, starting with 5 g. (0.05 mole) of 3-methylpiperidine and 2.5 g. (0.01 mole) of 3-chloro-5-chlorosulfonylbenzoic acid in 15 ml. of methylene chloride, providing 2.7 g., m.p. 177°-179° C. of the crude product. Purification is effected by recrystallization from acetone-hexane, 1.2 g.,m.p. 181°-183° C.

후처리

  1. customPurification
  2. customis effected by recrystallization from acetone-hexane, 1.2 g

출처 및 근거

ORD 기록
ord-c00072df2cbf494b9d1dfe2c09dcc8d4
출처 데이터셋
uspto-grants-1976_11
특허 번호
US03992441

반응 노트

불러오는 중…